Spyre Therapeutics (SYRE) Revenue (2015 - 2023)

Spyre Therapeutics posted quarterly Revenue of $688000.0 for Q2 2023, up 10.08% year-on-year from $625000.0 in Q2 2022, and up 247.47% on a QoQ basis from $198000.0 in Q1 2023.

Spyre Therapeutics (SYRE) has 7 years of Revenue data on file, last reported at $688000.0 in Q2 2023.

  • For the quarter ending Q2 2023, Revenue rose 10.08% year-over-year to $688000.0; the trailing twelve-month figure through Mar 2024 stood at $688000.0 (down 40.94% YoY), and the FY2023 full-year result was $886000.0, down 61.96% from the prior year.
  • Revenue for Q2 2023 stood at $688000.0, up from $198000.0 in the prior quarter.
  • Across five years, Revenue topped out at $12.0 million in Q2 2021 and bottomed at $168000.0 in Q4 2022.
  • The 3-year median for Revenue is $688000.0 (2023), against an average of $3.4 million.
  • The widest annual swing landed in 2022, when Revenue plunged 98.55%; it then rose 10.08% in 2023.
  • A 3-year view of Revenue shows it stood at $3.6 million in 2021, then plunged by 95.39% to $168000.0 in 2022, then soared by 309.52% to $688000.0 in 2023.
  • The last three Revenue figures came in at $688000.0 (Q2 2023), $198000.0 (Q1 2023), and $168000.0 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 Spyre Therapeutics 5.55 Bn 5.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 688,000.00
Mar 31, 2023 198,000.00
Dec 31, 2022 168,000.00
Sep 30, 2022 174,000.00
Jun 30, 2022 625,000.00
Mar 31, 2022 1.36 Mn
Dec 31, 2021 3.64 Mn
Sep 30, 2021 12.00 Mn
Jun 30, 2021 12.00 Mn
Jun 30, 2018 2.38 Mn
Mar 31, 2018 1.51 Mn
Dec 31, 2017 1.48 Mn
Sep 30, 2017 1.26 Mn
Jun 30, 2017 1.48 Mn
Mar 31, 2017 982,000.00
Dec 31, 2016 1.25 Mn
Sep 30, 2016 1.15 Mn
Jun 30, 2016 1.37 Mn
Mar 31, 2016 859,000.00
Dec 31, 2015 1.59 Mn
Sep 30, 2015 1.07 Mn
Jun 30, 2015 3.43 Mn